7Wang ML, Yung WK, Royce ME, et al. Capecitabine for 5 -fluo- rouracil-resistant brain metastases from breast cancer[J]. Am J Clin Oncol, 2001, 24(4): 421-424.
8Ekenel M, Hormigo AM, Peak S, et al. Capecitabine therapy of cen- tral nervous system metastases from breast Cancer[J]. J Neurooncol, 2007, 85(2): 223-227.
3Blum JL,Dieras V,Lo Russo PM,et al.Multicenter,phaseⅡstudy of capecitabine in taxane-pretreated metastatic breast carcinoma patients[J].Cancer,2001;92(7):1759-68.
4Miller KD,Chap LI,Holmes FA,et al.Randomized phaseⅢtrial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer[J].J Clin Oncol,2005;23(4):792-9.
5Reichardt P,Von Minckwitz G,Thuss-Patience PC,et al.Multicenter phaseⅡstudy of oral capecitabine(Xeloda)in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy[J].Ann Oncol,2003;14(8):1227-33.
6Ishikawa T,Utho M,Sawada N,et al.Tumor selective delivery of 5-fluorouracil by capecitabine,a new oral fluoropyrimidine carbamate,in human cancer xenografts[J].Biochem Pharmacol,1998;55(7):1091-7.
7Gennari A,Stockler M,Puntoni M,et al.Duration of chemotherapy for metastatic breast cancer:a systematic review and meta-analysis of randomized clinical trials[J].J Clin Oncol,2011;29(16):2144-9.
